These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22259215)

  • 1. Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap samples and the role of pre- and postcytology testing.
    Chernesky M; Jang D; Portillo E; Smieja M; Kapala J; Doucette C; Sumner J; Ewert R; MacRitchie C; Gilchrist J
    J Clin Microbiol; 2012 Apr; 50(4):1281-4. PubMed ID: 22259215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
    Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
    J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
    Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
    J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests.
    Moncada J; Schachter J; Liska S; Shayevich C; Klausner JD
    J Clin Microbiol; 2009 Jun; 47(6):1657-62. PubMed ID: 19369445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
    Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
    Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands.
    van Doornum GJ; Schouls LM; Pijl A; Cairo I; Buimer M; Bruisten S
    J Clin Microbiol; 2001 Mar; 39(3):829-35. PubMed ID: 11230391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of
    Van Der Pol B; Fife K; Taylor SN; Nye MB; Chavoustie SE; Eisenberg DL; Crane L; Hirsch G; Arcenas R; Marlowe EM
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.
    Masek BJ; Arora N; Quinn N; Aumakhan B; Holden J; Hardick A; Agreda P; Barnes M; Gaydos CA
    J Clin Microbiol; 2009 Jun; 47(6):1663-7. PubMed ID: 19386838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.
    Schachter J; Chernesky MA; Willis DE; Fine PM; Martin DH; Fuller D; Jordan JA; Janda W; Hook EW
    Sex Transm Dis; 2005 Dec; 32(12):725-8. PubMed ID: 16314767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation.
    Moncada J; Schachter J; Hook EW; Ferrero D; Gaydos C; Quinn TC; Willis D; Weissfeld A; Martin DH
    Sex Transm Dis; 2004 May; 31(5):273-7. PubMed ID: 15107628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Abbott RealTime CT/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Gaydos CA; Cartwright CP; Colaninno P; Welsch J; Holden J; Ho SY; Webb EM; Anderson C; Bertuzis R; Zhang L; Miller T; Leckie G; Abravaya K; Robinson J
    J Clin Microbiol; 2010 Sep; 48(9):3236-43. PubMed ID: 20668135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptima Combo 2 testing detected additional cases of Neisseria gonorrhoeae infection in men and women in community settings.
    Kapala J; Biers K; Cox M; Kamionka M; Sumner J; Toor R; Gilchrist J; Jang D; Smieja M; Chernesky M
    J Clin Microbiol; 2011 May; 49(5):1970-1. PubMed ID: 21411585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of
    Nye MB; Osiecki J; Lewinski M; Liesenfeld O; Young S; Taylor SN; Lillis RA; Body BA; Eisenhut C; Hook Iii EW; Van Der Pol B
    Sex Transm Infect; 2019 Mar; 95(2):87-93. PubMed ID: 30126947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.
    Chernesky M; Jang D; Luinstra K; Chong S; Smieja M; Cai W; Hayhoe B; Portillo E; Macritchie C; Main C; Ewert R
    J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population.
    Carroll KC; Aldeen WE; Morrison M; Anderson R; Lee D; Mottice S
    J Clin Microbiol; 1998 Jun; 36(6):1630-3. PubMed ID: 9620391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium.
    Koumans EH; Black CM; Markowitz LE; Unger E; Pierce A; Sawyer MK; Papp JR
    J Clin Microbiol; 2003 Apr; 41(4):1507-11. PubMed ID: 12682137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Nucleic Acid Amplification Testing for Diagnosis of Extragenital Sexually Transmitted Infections.
    Cosentino LA; Danby CS; Rabe LK; Macio I; Meyn LA; Wiesenfeld HC; Hillier SL
    J Clin Microbiol; 2017 Sep; 55(9):2801-2807. PubMed ID: 28679521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.
    Lowe P; O'Loughlin P; Evans K; White M; Bartley PB; Vohra R
    J Clin Microbiol; 2006 Jul; 44(7):2619-21. PubMed ID: 16825397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay.
    Cheng A; Qian Q; Kirby JE
    J Clin Microbiol; 2011 Apr; 49(4):1294-300. PubMed ID: 21325546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a new Pap test-based method for screening of Chlamydia trachomatis and Neisseria gonorrhoeae using liquid-based cytology media.
    Martens MG; Fine P; Fuller D; Ginde SY; Hook EW; Lebed J; Mena L; Taylor SN; Van Der Pol B
    South Med J; 2013 Sep; 106(9):506-12. PubMed ID: 24002555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.